top of page
Home: Welcome
Chemistry Main Banner.jpg

Our Goal is Cure

We are a pharmaceutical company focused on developing drugs and methods for the cure of metastatic cancer.

Our pipeline of clinical and preclinical studies covers a range of solid tumors and blood cancers. The first treatment in our pipeline to reach the clinical trial phase is one for metastatic cancers that arise in the setting of an inherited BRCA1, BRCA2, or PALB2 mutation.

Home: Clinica Trial

We have a rich pipeline of investigational cancer treatments.


Our unique approach to designing new cancer drugs and comprehensive treatments is what sets us apart.

Clinical trials are the gold standard for evaluating the benefits of an investigational treatment.


Read our latest press release:

Boston Patent Law Association Honors General Oncology’s Founder for Invention of Novel Investigational Chemotherapy

(November 15, 2022)

BPLA Photo.jpg
bottom of page